US2214133058 - Common Stock
1.05 -0.09 (-7.89%)
After market: 1.06 +0.01 (+0.95%)
COSMOS HEALTH INC
NASDAQ:COSM (12/8/2023, 7:00:01 PM)After market: 1.06 +0.01 (+0.95%)
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois and currently employs 102 full-time employees. The company went IPO on 2010-05-19. The firm is engaged in the nutraceuticals sector through its own proprietary lines of products, Sky Premium Life and Mediterranation. The firm also operates in the pharmaceutical sector through the provision of a broad line of branded generics and over the counter (OTC) medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and the United Kingdom serving retail pharmacies and wholesale distributors. The firm is also engaged in the research and development (R&D) of novel patented nutraceuticals (IP) and specialized root extracts as well as in the R&D of proprietary complex generics and OTC products. The firm also provides a global distribution platform. The Company’s subsidiary, Pharmaceutical Laboratories CANA S.A., (Cana), manufactures, sells, distributes, and markets original branded products researched and developed by global pharmaceutical and healthcare companies.
COSMOS HEALTH INC
141 W. Jackson Blvd, Suite 4236
Cosmos Health acquires AI-powered platform, Cloudscreen, in a deal exceeding $5M.
The healthcare industry has historically provided good returns to investors, however there are also healthcare stocks you will want to sell.
NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a new growth report on Cosmos Health Inc., a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform.
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!
Here you can normally see the latest stock twits on COSM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.